Clinical trial
Biomarker-Driven Pharmacological Treatment for Autism Spectrum Disorder
NCT05063656 is registered in ClinicalTrials.gov with David Cochran as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarker-Driven Pharmacological Treatment for Autism Spectrum Disorder
- Lead sponsor
- David Cochran
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 4, 2022
- Completion date
- December 31, 2025
- Enrollment
- 16 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.